<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.39856.013</object-id><label>Table 2.</label><caption><title>Bayesian GWAS using mortality risk factors reveals seven additional genome-wide significant variants.</title><p>At or near &#8211; Gene or set of genes nearest to the index SNP; rsID &#8211; The index SNP with the lowest P value in the risk factor-informed analysis. Chr &#8211; Chromosome; Position &#8211; Base-pair position on chromosome (GRCh37); A1 &#8211; the effect allele, increasing lifespan; Freq1 &#8211; Frequency of the A1 allele; Years1 &#8211; Years of life gained for carrying one copy of the A1 allele; SE &#8211; Standard Error; CES P &#8211; the P value for the Wald test of association between imputed dosage and cox model residual, under the assumption of common effects between sexes. Risk &#8211; mortality risk factors associated with the variant (p &lt; 3.81 &#215; 10<sup>&#8722;5</sup>, accounting for 82 independent SNPs and 16 independent factors). BF P &#8211; Empirical P value derived from permutating Bayes Factors. See <xref ref-type="supplementary-material" rid="table2sdata1">Table 2&#8212;source data 1</xref> for the causal estimate of each risk factor. See <xref ref-type="supplementary-material" rid="table2sdata2">Table 2&#8212;source data 2</xref> for all SNPs significant at FDR&#160;&lt;&#160;1%.</p><p><supplementary-material id="table2sdata1"><object-id pub-id-type="doi">10.7554/eLife.39856.014</object-id><label>Table 2&#8212;source data 1.</label><caption><title>Bayesian GWAS - Multivariate effect estimates for the 16 traits chosen by the AIC based stepwise model selection.</title><p>The multivariate MR identified 16 traits (58 tested, see <xref ref-type="bibr" rid="bib45">McDaid et al., 2017</xref> for an exhaustive list) with significant causal effect on lifespan and used the effect estimates to create the prior assumption of the expected effect size of each variant on lifespan, in the (Bayesian) iGWAS.&#160;Effect Estimate &#8211; the estimated effect of standardized trait on standardized lifespan, in multivariate model. SE &#8211; the standard error of the estimated effect, in multivariate model. P &#8211; the P value (two sided) from MR, for testing association between standardized trait and standardized lifespan, in multivariate model.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-39856-table2-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="table2sdata2"><object-id pub-id-type="doi">10.7554/eLife.39856.015</object-id><label>Table 2&#8212;source data 2.</label><caption><title>82 SNPs significantly associated with lifespan at 1% FDR and the SNP&#8217;s associations with risk factors.</title><p>Bayesian iGWAS was performed using observed association results from CES GWAS and priors from 16 risk factors selected by AIC based stepwise model selection. Bayes Factors were calculated to compare effect estimates observed in the conventional GWAS to the prior effect computed. Empirical P values were assigned using a permutation approach and further corrected for multiple testing using Benjamini-Hochberg correction. Chr &#8211; Chromosome, Position &#8211; Base-pair position on chromosome (GRCh37), A1 &#8211; Effect Allele, Freq1 &#8211; Frequency of the A1 allele (from conventional GWAS), Beta1&#160;(from conventional GWAS), SE &#8211; Standard Error of Beta1, Years &#8211; Years of lifespan gained for carrying one copy of the A1 allele (from conventional GWAS), P &#8211; P value (from conventional GWAS), PriorEffect &#8211; Prior effect estimate calculated from the summary statistics data for the 16 risk factors identified, PriorSE &#8211; Standard Error of the prior effect estimate, LogBF &#8211; Log of the observed Bayes Factor, P_BF &#8211; Empirical P value from a permutation approach for the log Bayes Factor. Final columns show the P value of each SNP in the studies used to calculate the prior, if the P value is significant after Bonferroni multiple testing correction (p &lt; 3.81 &#215; 10<sup>&#8722;5</sup>, 82*16 tests) the cell is shaded green. Counts of these significant associations by SNP/trait are shown in the final column/row.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-39856-table2-data2-v2.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">At or near</th><th valign="top">rsID</th><th valign="top">Chr</th><th valign="top">Position</th><th valign="top">A1</th><th valign="top">Freq1</th><th valign="top">Years1</th><th valign="top">SE</th><th valign="top">CES P</th><th valign="top">Risk</th><th valign="top">BF P</th></tr></thead><tbody><tr><td valign="top">CELSR2/PSRC1</td><td valign="top">rs4970836</td><td valign="top">1</td><td valign="top">109821797</td><td valign="top">G</td><td valign="top">0.23</td><td valign="top">0.2234</td><td valign="top">0.0463</td><td valign="top">1.4E-06</td><td valign="top">LDL <break/>HDL <break/>CAD</td><td valign="top">1.6E-09</td></tr><tr><td valign="top">TMEM18</td><td valign="top">rs6744653</td><td valign="top">2</td><td valign="top">628524</td><td valign="top">A</td><td valign="top">0.17</td><td valign="top">0.2772</td><td valign="top">0.0511</td><td valign="top">5.8E-08</td><td valign="top">BMI</td><td valign="top">7.0E-10</td></tr><tr><td valign="top">GBX2/ASB18</td><td valign="top">rs10211471</td><td valign="top">2</td><td valign="top">237081854</td><td valign="top">C</td><td valign="top">0.80</td><td valign="top">0.2401</td><td valign="top">0.0493</td><td valign="top">1.1E-06</td><td valign="top">Education</td><td valign="top">2.3E-08</td></tr><tr><td valign="top">IGF2R</td><td valign="top">rs111333005</td><td valign="top">6</td><td valign="top">160487196</td><td valign="top">G</td><td valign="top">0.98</td><td valign="top">0.8665</td><td valign="top">0.1577</td><td valign="top">3.9E-08</td><td valign="top">LDL <break/>CAD</td><td valign="top">6.6E-09</td></tr><tr><td valign="top">POM121C</td><td valign="top">rs113160991</td><td valign="top">7</td><td valign="top">75094329</td><td valign="top">G</td><td valign="top">0.78</td><td valign="top">0.2541</td><td valign="top">0.0495</td><td valign="top">2.8E-07</td><td valign="top">BMI <break/>Insulin</td><td valign="top">7.5E-09</td></tr><tr><td valign="top">ZC3HC1</td><td valign="top">rs56179563</td><td valign="top">7</td><td valign="top">129685597</td><td valign="top">A</td><td valign="top">0.39</td><td valign="top">0.2107</td><td valign="top">0.0406</td><td valign="top">2.1E-07</td><td valign="top">CAD</td><td valign="top">5.6E-09</td></tr><tr><td valign="top">ABO</td><td valign="top">rs2519093</td><td valign="top">9</td><td valign="top">136141870</td><td valign="top">C</td><td valign="top">0.81</td><td valign="top">0.2244</td><td valign="top">0.0497</td><td valign="top">6.3E-06</td><td valign="top">LDL <break/>CAD</td><td valign="top">1.9E-08</td></tr></tbody></table></table-wrap>